rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BeyondSpring, Inc. -

BYSI · Nasdaq

Health CareBiotechnologyNot moving yet

BYSI stood above a rising 150-day average in 4 of the last 52 weekly readings, and has been out of that trend for the last 46 weeks. It is 59.2% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 46
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
22 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 4 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.1M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders22+4 on the quarter
New · exited4 · 0
Reported value$10.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Decheng Capital LLCunchanged · filed 14 Aug 20263,800,702$6.7M00.0%
BlackRock, Inc.added · filed 7 Aug 2026672,915$1.2M+23,453+3.6%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026626,457$1.1M+18,523+3.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026367,740$644K-7,631−2.0%
STATE STREET CORPunchanged · filed 7 Aug 2026231,120$404K00.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026181,196$317K+1,271+0.7%
UBS Group AGadded · filed 13 Aug 202663,032$110K+61,862+5287.4%
NORTHERN TRUST CORPreduced · filed 13 Aug 202662,024$109K-7,244−10.5%
Meridian Wealth Management, LLCunchanged · filed 5 Aug 202615,000$26K00.0%
Farther Finance Advisors, LLCnew · filed 17 Jul 202612,773$22K+12,773
31 Mar 2023 – 30 Jun 2026
121722Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jiangwen Majeti Company insiderDirector · last 1 Jul 20260 · 0
Min Qiu Company insiderChief Executive Officer · last 1 Jul 20260 · 0
Brendan Delaney Company insiderDirector · last 1 Apr 20260 · 0
Lan Huang Company insiderChief Executive Officer · last 1 Apr 20260 · 0
Matthew Kirkby Company insiderDirector · last 1 Apr 20260 · 0
Patrick Fabbio Company insiderDirector · last 1 Apr 20260 · 0
Sihai Xu Company insiderDirector · last 1 Apr 20260 · 0
Yingjuan June Lu Company insiderChief Scientific Officer · last 1 Apr 20260 · 0
Decheng Capital China Life Sciences Usd Fund Ii, L.p. Company insider10% owner · last 17 Oct 20250 · 8
Decheng Capital Global Healthcare Gp, Llc Company insider10% owner · last 15 Oct 20250 · 12
Decheng Capital Management Iii (Cayman), Llc Company insider10% owner · last 7 Oct 20250 · 12
Xiangmin Cui Company insider10% owner · last 2 Oct 20250 · 24

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-72.4%
Share count trendFY 2024 · to 28 Feb 20250.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.8M
Free cash flowFY 2025 · to 31 Dec 2025−$19.8M

Analyst forecasts

No analyst forecasts yet.